FAS and non-small cell lung carcinoma: For example, Li et al. indicated that the prognosis (PFS and OS) of FAS 670 A > G polymorphism GG genotype for advanced non-small cell lung cancer (NSCLC) patients accepted platinum-based adjuvant treatment was worse than that of GA or AA genotype 31.